Posts for Ticker ‘CVD’

Today’s Best Market Rumors (10/28/2009) (UBS)(SNE)(BCS)(CBS)

newspaperUpdated throughout the day.

Update 12.05 PM EST:  UBS (NYSE:UBS) may spin off PaineWebber  (Breakingviews)

GMAC has asked the Treasury Department for several billion more dollars in loans. (NYTimes)

Barry Diller’s IACI (NASDAQ:IACI) might be willing to sell its search business.  (NYPost)

News Corp (NYSE:NWS) and CBS (NYSE:CBS) are trying to get cable companies including Time Warner Cable (NYSE:TWC) to pay for carrying their broadcast channels.  (WSJ)

Statistics on ”global cooling” may be bogus.  (Ars Technica)

AMD’s (NYSE:AMD) former CEO Hector Ruiz may have leaked tips to one of the people accused of insider trading in the Galleon case.  (various)

The German hedge fund firm K1 is part of an international criminal investigation after allegedly stiffing banks including Barclays (NYSE:BCS), JPMorgan Chase (NYSE:JPM). and BNP Paribas with $400 million of losses.  (Bloomberg)

Covance (NYSE:CVD) shares are undervalued by 50%  (BusinessWeek)

Sony (NYSE:SNE) is expected to loss money for the fourth straight quarter.  (Forbes)

Douglas A. McIntyre

Posted on: October 28, 2009 – 9:13 am in Rumors, , , , , , , , , ,

Top Analyst Upgrades (BCSI, CVD, TRAK, DNDN, DISH, GYMB, HPQ, M, BTU, PETM, X)

These are this Tuesday morning’s top pre-market analyst upgrades and positive research calls seen from Wall Street:

Blue Coat Systems (BCSI) started as Buy at BofA/Merrill.
Covance (CVD) upgraded to Buy at Jefferies.
DealerTrack Holdings (TRAK) upgraded to Outperform at Cowen.
Dendreon (DNDN) Started as Outperform at Leerink Swann.
DISH Network (DISH) upgraded to Outperform at Wells Fargo.
Gymboree (GYMB) upgraded to Outperform at FBR Capital.
Hewlett-Packard (HPQ) upgraded to Outperform at Credit Suisse.
Macy’s (M) upgraded to Buy at Citigroup.
Peabody Energy (BTU) upgraded to Buy at Citigroup.
Petsmart (PETM) Started as Overweight at Thomas Weisel.
US Steel (X) upgraded to Neutral at BofA/Merrill.

You can join our open email distribution list which goes out several times per week for top analyst upgrades and downgrades, top day trader alerts, IPO’s, key secondary offerings, guru investor data on Buffett and others, mergers, and more.

JON C. OGG

Posted on: September 22, 2009 – 8:17 am in Analyst Calls, , , , , , , , , , ,

Top Analyst Upgrades (AXP, KMX, CNQ, COF, CERN, CVD, ENOC, QLGC, QCOM, DIS)

These are some of the top pre-market analyst upgrades and positive initiations we have seen early this Thursday morning:
American Express (AXP) Raised to Neutral from Underweight at JPMorgan.
CarMax (KMX) Started as Buy at Rochdale.
Canadian Natural (CNQ) Raised to outperform at CIBC.
Capital One (COF) Raised to Buy at Jefferies.
Cerner (CERN) Started as Outperform at William Blair.
Covance CVD) Started as Outperform at JPMorgan.
enerNOC (ENOC) Raised to Outperform at Baird.
QLogic (QLGC) Raised to Buy at ThinkEquity.
QUALCOMM (QCOM) Started as Outperform at RBC.
Walt Disney (DIS) Raised to Outperform at Bernstein.

JON C. OGG

Posted on: July 16, 2009 – 7:18 am in Uncategorized, , , , , , , , , ,

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

Money_stack_picIt is getting pretty thin in major analyst coverage as firms are encouraged to go easy on major year-end calls barring anything unexpected.  These are the top analyst upgrades, downgrades, and new coverage calls we have seen this Tuesday morning:

  • AECOM (ACM) Started as Outperform at Baird.
  • Axsys Technologies (AXYS) Raised to Outperform at Morgan Keegan.
  • Cintas (CTAS) Started as Overweight at JPMorgan.
  • Covance (CVD) Started as Buy at Piper Jaffray.
  • Gilead (GILD) Started as Buy at Stanford Group.
  • PPD Inc. (PPDI) STarted as Buy at Piper Jaffray.
  • VisionChina Media (VISN) Strated as Buy at Piper Jaffray.
  • Environmental Power Corp. (EPG) Cut to Neutral at Merriman Curhan Ford.
  • inVentiv Health (VTIV) Cut to Hold at Jefferies.

Jon C. Ogg
December 23, 2008

Posted on: December 23, 2008 – 7:38 am in Analyst Calls, , , , , , , , ,

Top 10 Pre-Market Analyst Calls (AXP, COF, DFS, ADBL, RATE, BRCM, CVC, CRL, CVD, GME, HAL, PALM, STI)

These are not the only upgrades and downgrades affecting shares in pre-market trading today, but these are the initial calls that 247WallSt.com is focusing on:

  • American Express (NYSE: AXP), Capital One (NYSE: COF), and Discover Financial (NYSE: DFS) downgraded to Sell at UBS.
  • Audible (NASDAQ: ADBL) downgraded to Market Perform at JMP Securities; downgraded to Hold at Jefferies.
  • Bankrate (NASDAQ: RATE) downgraded to Hold at Citigroup; downgraded to Neutral at Merriman Curhan Ford.
  • Broadcom (NASDAQ: BRCM) downgraded to Neutral from Overweight at JPMorgan.
  • Cablevision (NYSE: CVC) raised to Buy from Hold at Deutsche Bank.
  • Charles River (NYSE: CRL) and Covance (NYSE: CVD) raised to Buy from Neutral at UBS.
  • Gamestop (NYSE: GME) raised to Buy from Hold at Citigroup.
  • Halliburton (NYSE: HAL) raised to Overweight from Neutral at JPMorgan.
  • Palm (NASDAQ: PALM) raised to Overweight from Underweight at JPMorgan.
  • SunTrust (NYSE: STI) downgraded to Underperform from Neutral at Robert W. Baird.

Jon C. Ogg
February 4, 2008

Posted on: February 4, 2008 – 7:16 am in Analyst Calls, , , , , , , , , , , , ,

Cramer’s Drug Research/CRO Stocks (CVD, PRXL)

On tonight’s MAD MONEY on CNBC, Jim Cramer came out with a positive tease early on in the contract research organization sector (CRO’s) as it pertains to drugs, biotech, and medical research.  He thinks this sector is recession proof and is set to continue growing whether the market rises or falls.  For growth and cost cutting this sector is mandatory for an ailing drug and pharma sector.  His picks tonight were:

  • His pick that does both early and late stage: Covance (NYSE: CVD) is Cramer’s best pick of the group and is 50/50 in early and late stages and a high customer diversification.  They can save customers the most by outsourcing, and the balance sheet is immaculate with new factories/offices opening.
  • Paraxel (NASDAQ:PRXL) is another he likes in the CRO sector.

This sector has seen some incredible performance over the last 12 to 18 months, yet only Quest has a $10 Billion market cap.  The multiples have gotten higher of late, but that is the price for being defensive now.  He isn’t at all convinced that today is the start of a market trend and he thinks the market will roll over again, so he wants to look at safety names besides tonight’s key oversold and overlooked tech stock picks he gave tonight.

Jon C. Ogg
January 14, 2008

Posted on: January 14, 2008 – 7:16 pm in Cramer, Drug companies, ,